Warning: The NCBI web site requires JavaScript to function. more...
The present and future role of bisphosphonates in the management of patients with breast cancer.
Brown JE, Coleman RE.
Breast Cancer Res. 2002;4(1):24-9. Epub 2001 Nov 26. Review.
Related citations
Bisphosphonates for breast cancer.
Pavlakis N, Schmidt R, Stockler M.
Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003474. Review.
Optimising treatment of bone metastases by Aredia(TM) and Zometa(TM).
Coleman RE.
Breast Cancer. 2000;7(4):361-9.
The role of bisphosphonates in breast and prostate cancers.
Brown JE, Neville-Webbe H, Coleman RE.
Endocr Relat Cancer. 2004 Jun;11(2):207-24. Review.
Bisphosphonates in the prevention and treatment of bone metastases.
Ramaswamy B, Shapiro CL.
Oncology (Williston Park). 2003 Sep;17(9):1261-70; discussion 1270-2, 1277-8, 1280. Review.
Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer.
Paterson AH, Kanis JA, Powles TJ, McCloskey E, Hanson J, Ashley S.
Can J Oncol. 1995 Dec;5 Suppl 1:54-7.
Bisphosphonates for advanced prostate cancer.
Yuen KK, Shelley M, Sze WM, Wilt T, Mason MD.
Cochrane Database Syst Rev. 2006 Oct 18;(4):CD006250. Review.
The clinical and cost considerations of bisphosphonates in preventing bone complications in patients with metastatic breast cancer or multiple myeloma.
McCloskey EV, Guest JF, Kanis JA.
Drugs. 2001;61(9):1253-74. Review.
Pharmacotherapy of bone metastases in breast cancer patients.
Petrut B, Simmons C, Broom R, Trinkaus M, Clemons M.
Expert Opin Pharmacother. 2008 Apr;9(6):937-45. Review.
The role of bisphosphonates in breast cancer management: review article.
Pickering LM, Mansi JL.
Curr Med Res Opin. 2002;18(5):284-95. Review.
Actions of bisphosphonates in animal models of breast cancer.
Padalecki SS, Guise TA.
Breast Cancer Res. 2002;4(1):35-41. Epub 2001 Dec 20. Review.
A systematic review of the role of bisphosphonates in metastatic disease.
Ross JR, Saunders Y, Edmonds PM, Patel S, Wonderling D, Normand C, Broadley K.
Health Technol Assess. 2004;8(4):1-176. Review.
Treatment of breast cancer with bone metastasis: bisphosphonate treatment - current and future.
Kohno N.
Int J Clin Oncol. 2008 Feb;13(1):18-23. Epub 2008 Feb 29. Review.
Antitumour effects of bisphosphonates: first evidence and possible mechanisms.
Diel IJ.
Drugs. 2000 Mar;59(3):391-9. Review.
Prevention of bone metastases from breast cancer by adjuvant bisphosphonate therapy.
Kohno N, Kokufu I.
Breast Cancer. 2003;10(1):33-7. Review.
New generation of bisphosphonates: broad clinical utility in breast and prostate cancer.
Rosen LS.
Oncology (Williston Park). 2004 May;18(5 Suppl 3):26-32. Review.
Management of bone metastases.
Oncologist. 2000;5(6):463-70. Review.
Adjuvant bisphosphonate therapy for breast cancer patients: Standard of care or future direction?
Freedman OC, Amir E, Clemons MJ.
Crit Rev Oncol Hematol. 2009 Oct;72(1):56-64. Epub 2009 Mar 23. Review.
Bisphosphonates in oncology: physiopathologic bases and clinical activity.
Riccardi A, Grasso D, Danova M.
Tumori. 2003 May-Jun;89(3):223-36. Review.
New results from the use of bisphosphonates in cancer patients.
Coleman R, Gnant M.
Curr Opin Support Palliat Care. 2009 Sep;3(3):213-8. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on